Journal of Molecular and Cellular Cardiology
Volume 47, Issue 2 , Pages 196-202 , August 2009

C-reactive protein impairs coronary arteriolar dilation to prostacyclin synthase activation: Role of peroxynitrite

  • Travis W. Hein

      Affiliations

    • Scott and White Memorial Hospital, Department of Surgery, College of Medicine, Texas A&M Health Science Center, 702 Southwest H.K. Dodgen Loop, Temple, TX 76504, USA
    • Corresponding Author InformationCorresponding author. Tel.: +1 254 724 3550; fax: +1 254 742 7181.
    • These authors contributed equally to this work.
    • ,
  • Erion Qamirani

      Affiliations

    • Department of Systems Biology and Translational Medicine, Cardiovascular Research Institute, College of Medicine, Texas A&M Health Science Center, Temple, TX 76504, USA
    • These authors contributed equally to this work.
    • ,
  • Yi Ren

      Affiliations

    • Department of Systems Biology and Translational Medicine, Cardiovascular Research Institute, College of Medicine, Texas A&M Health Science Center, Temple, TX 76504, USA
    • ,
  • Lih Kuo

      Affiliations

    • Scott and White Memorial Hospital, Department of Surgery, College of Medicine, Texas A&M Health Science Center, 702 Southwest H.K. Dodgen Loop, Temple, TX 76504, USA
    • Department of Systems Biology and Translational Medicine, Cardiovascular Research Institute, College of Medicine, Texas A&M Health Science Center, Temple, TX 76504, USA

Received 5 March 2009 ,Revised 23 April 2009 ,Accepted 24 April 2009.

References 

  1. Stuehr DJ. Mammalian nitric oxide synthases. Biochim. Biophys. Acta. 1999;1411:217–230
  2. Smith WL, Garavito RM, DeWitt DL. Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J. Biol. Chem. 1996;271:33157–33160
  3. Thengchaisri N, Kuo L. Hydrogen peroxide induces endothelium-dependent and -independent coronary arteriolar dilation: role of cyclooxygenase and potassium channels. Am. J. Physiol. Heart Circ. Physiol. 2003;285:H2255–H2263
  4. Davies MG, Hagen PO. The vascular endothelium. A new horizon. Ann. Surg. 1993;218:593–609
  5. Neri Serneri G, Gensini G, Abbate R, Castellani S, Bonechi F, Carnovali M, et al. Defective coronary prostaglandin modulation in anginal patients. Am. Heart J. 1990;120:12–21
  6. Libby P, Ridker PM. Inflammation and atherosclerosis: role of C-reactive protein in risk assessment. Am. J. Med. 2004;116:9S–16S
  7. Watson T, Goon PK, Lip GY. Endothelial progenitor cells, endothelial dysfunction, inflammation, and oxidative stress in hypertension. Antioxid. Redox. Signal. 2008;10:1079–1088
  8. Aljada A. Endothelium, inflammation, and diabetes. Metab. Syndr. Relat. Disord. 2003;1:3–21
  9. Ridker PM, Danielson E, Fonseca FA, Genest J, Gotto AM, Kastelein JJ, et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N. Engl. J. Med. 2008;359:2195–2207
  10. Jialal I, Devaraj S, Venugopal SK. C-reactive protein: risk marker or mediator in atherothrombosis?. Hypertension. 2004;44:6–11
  11. Mineo C, Gormley A, Yunahnn I, Osborne-Lawrence S, Gibson L, Hahner L, et al. FCγRIIB mediates C-reactive protein inhibition of endothelial NO synthase. Circ. Res. 2005;97:1124–1131
  12. Venugopal SK, Devaraj S, Yuhanna I, Shaul P, Jialal I. Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells. Circulation. 2002;106:1439–1441
  13. Verma S, Wang CH, Li SH, Dumont AS, Fedak PW, Badiwala MV, et al. A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis. Circulation. 2002;106:913–919
  14. Pasceri V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells. Circulation. 2000;102:2165–2168
  15. Venugopal SK, Devaraj S, Jialal I. C-reactive protein decreases prostacyclin release from human aortic endothelial cells. Circulation. 2003;108:1676–1678
  16. Wang CH, Li SH, Weisel RD, Fedak PW, Dumont AS, Szmitko P, et al. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle. Circulation. 2003;107:1783–1790
  17. Qamirani E, Ren Y, Kuo L, Hein TW. C-reactive protein inhibits endothelium-dependent NO-mediated dilation in coronary arterioles by activating p38 kinase and NAD(P)H oxidase. Arterioscler. Thromb. Vasc. Biol. 2005;25:995–1001
  18. Nagaoka T, Kuo L, Ren Y, Yoshida A, Hein TW. C-reactive protein inhibits endothelium-dependent nitric oxide-mediated dilation of retinal arterioles via enhanced superoxide production. Invest. Ophthalmol. Vis. Sci. 2008;49:2053–2060
  19. Grad E, Golomb M, Mor-Yosef I, Koroukhov N, Lotan C, Edelman ER, et al. Transgenic expression of human C-reactive protein suppresses endothelial nitric oxide synthase expression and bioactivity after vascular injury. Am. J. Physiol. Heart Circ. Physiol. 2007;293:H489–H495
  20. Schwartz R, Osborne-Lawrence S, Hahner L, Gibson LL, Gormley AK, Vongpatanasin W, et al. C-reactive protein downregulates endothelial NO synthase and attenuates reendothelialization in vivo in mice. Circ. Res. 2007;100:1452–1459
  21. Teoh H, Quan A, Lovren F, Wang G, Tirgari S, Szmitko PE, et al. Impaired endothelial function in C-reactive protein overexpressing mice. Atherosclerosis. 2008;201:318–325
  22. Zou MH, Leist M, Ullrich V. Selective nitration of prostacyclin synthase and defective vasorelaxation in atherosclerotic bovine coronary arteries. Am. J. Pathol. 1999;154:1359–1365
  23. Zou MH, Cohen R, Ullrich V. Peroxynitrite and vascular endothelial dysfunction in diabetes mellitus. Endothelium. 2004;11:89–97
  24. Kuo L, Chilian WM, Davis MJ. Interaction of pressure- and flow-induced responses in porcine coronary resistance vessels. Am. J. Physiol. 1991;261:H1706–H1715
  25. Zhang C, Hein TW, Wang W, Chang CI, Kuo L. Constitutive expression of arginase in microvascular endothelial cells counteracts nitric oxide-mediated vasodilatory function. FASEB J. 2001;15:1264–1266
  26. Hein TW, Liao JC, Kuo L. oxLDL specifically impairs endothelium-dependent, NO-mediated dilation of coronary arterioles. Am. J. Physiol. Heart Circ. Physiol. 2000;278:H175–H183
  27. Hardy P, Abran D, Hou X, Lahaie I, Peri K, Asselin P, et al. A major role for prostacyclin in nitric oxide-induced ocular vasorelaxation in the piglet. Circ. Res. 1998;83:721–729
  28. Yeh ET, Willerson JT. Coming of age of C-reactive protein: using inflammation markers in cardiology. Circulation. 2003;107:370–371
  29. Zhang C, Hein TW, Wang W, Kuo L. Divergent roles of angiotensin II AT1 and AT2 receptors in modulating coronary microvascular function. Circ. Res. 2003;92:322–329
  30. Schnackenberg CG, Wilcox CS. Two-week administration of tempol attenuates both hypertension and renal excretion of 8-iso prostaglandin F2α. Hypertension. 1999;33:424–428
  31. Li H, Gutterman DD, Rusch NJ, Bubolz A, Liu Y. Nitration and functional loss of voltage-gated K+ channels in rat coronary microvessels exposed to high glucose. Diabetes. 2004;53:2436–2442
  32. Kuo L, Chilian WM, Davis MJ, Laughlin MH. Endotoxin impairs flow-induced vasodilation of porcine coronary arterioles. Am. J. Physiol. 1992;262:H1838–H1845
  33. Hein TW. Kuo L. cAMP-independent dilation of coronary arterioles to adenosine: role of nitric oxide, G proteins, and KATP channels. Circ. Res. 1999;85:634–642
  34. Hink U, Oelze M, Kolb P, Bachschmid M, Zou MH, Daiber A, et al. Role for peroxynitrite in the inhibition of prostacyclin synthase in nitrate tolerance. J. Am. Coll. Cardiol. 2003;42:1826–1834
  35. Zou MH, Bachschmid M. Hypoxia-reoxygenation triggers coronary vasospasm in isolated bovine coronary arteries via tyrosine nitration of prostacyclin synthase. J. Exp. Med. 1999;190:135–139
  36. Anderson R, Dart AM, Starr J, Shaw J, Chin-Dusting JP. Plasma C-reactive protein, but not protein S, VCAM-1, von Willebrand factor or P-selectin, is associated with endothelium dysfunction in coronary artery disease. Atherosclerosis. 2004;172:345–351
  37. Fichtlscherer S, Breuer S, Schachinger V, Dimmeler S, Zeiher AM. C-reactive protein levels determine systemic nitric oxide bioavailability in patients with coronary artery disease. Eur. Heart J. 2004;25:1412–1418
  38. Teragawa H, Fukuda Y, Matsuda K, Ueda K, Higashi Y, Oshima T, et al. Relation between C reactive protein concentrations and coronary microvascular endothelial function. Heart. 2004;90:750–754
  39. Tomai F, Ribichini F, Ghini AS, Ferrero V, Ando G, Vassanelli C, et al. Elevated C-reactive protein levels and coronary microvascular dysfunction in patients with coronary artery disease. Eur. Heart J. 2005;26:2099–2105
  40. Date H, Imamura T, Sumi T, Ishikawa T, Kawagoe J, Onitsuka H, et al. Effects of interleukin-6 produced in coronary circulation on production of C-reactive protein and coronary microvascular resistance. Am. J. Cardiol. 2005;95:849–852
  41. Devaraj S, Venugopal S, Jialal I. Native pentameric C-reactive protein displays more potent pro-atherogenic activities in human aortic endothelial cells than modified C-reactive protein. Atherosclerosis. 2006;184:48–52
  42. Singh U, Devaraj S, Vasquez-Vivar J, Jialal I. C-reactive protein decreases endothelial nitric oxide synthase activity via uncoupling. J. Mol. Cell. Cardiol. 2007;43:780–791
  43. Beckman JS, Koppenol WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am. J. Physiol. 1996;271:C1424–C1437
  44. Beckman JS, Chen J, Ischiropoulos H, Crow JP. Oxidative chemistry of peroxynitrite. Methods Enzymol. 1994;233:229–240
  45. Zou M, Jendral M, Ullrich V. Prostaglandin endoperoxide-dependent vasospasm in bovine coronary arteries after nitration of prostacyclin synthase. Br. J. Pharmacol. 1999;126:1283–1292
  46. Spisni E, Griffoni C, Santi S, Riccio M, Marulli R, Bartolini G, et al. Colocalization prostacyclin (PGI2) synthase–caveolin-1 in endothelial cells and new roles for PGI2 in angiogenesis. Exp. Cell. Res. 2001;266:31–43
  47. Shaul PW, Smart EJ, Robinson EJ, German Z, Yuhanna IS, Ying Y, et al. Acylation targets endothelial nitric-oxide synthase to plasmalemmal caveolae. J. Biol. Chem. 1996;271:6518–6522
  48. Ushio-Fukai M. Localizing NADPH oxidase-derived ROS. Sci. STKE. 2006;8:
  49. Guzik T, West N, Pillai R, Taggart D, Channon K. Nitric oxide modulates superoxide release and peroxynitrite formation in human blood vessels. Hypertension. 2002;39:1088–1094
  50. Kuo L, Davis MJ, Chilian WM. Myogenic activity in isolated subepicardial and subendocardial coronary arterioles. Am. J. Physiol. 1988;255:H1558–H1562
  51. Hein TW, Zhang C, Wang W, Kuo L. Heterogeneous β2-adrenoceptor expression and dilation in coronary arterioles across the left ventricular wall. Circulation. 2004;110:2708–2712
  52. Zhang C, Hein TW, Kuo L. Transmural difference in coronary arteriolar dilation to adenosine: effect of luminal pressure and KATP channels. Am. J. Physiol. Heart Circ. Physiol. 2000;279:H2612–H2619
  53. Sorop O, Spaan JA, VanBavel E. Pulsation-induced dilation of subendocardial and subepicardial arterioles: effect on vasodilator sensitivity. Am. J. Physiol. Heart Circ. Physiol. 2002;282:H311–H319
  54. Merkus D, Vergroesen I, Hiramatsu O, Tachibana H, Nakamoto H, Toyota E, et al. Stenosis differentially affects subendocardial and subepicardial arterioles in vivo. Am. J. Physiol. Heart Circ. Physiol. 2001;280:H1674–H1682
  55. Goto M, VanBavel E, Giezeman MJ, Spaan JA. Vasodilatory effect of pulsatile pressure on coronary resistance vessels. Circ. Res. 1996;79:1039–1045
  56. Zhang C, Hein TW, Wang W, Miller MW, Fossum TW, McDonald MM, et al. Upregulation of vascular arginase in hypertension decreases nitric oxide-mediated dilation of coronary arterioles. Hypertension. 2004;44:935–943
  57. Gulec S, Ozdemir AO, Maradit-Kremers H, Dincer I, Atmaca Y, Erol C. Elevated levels of C-reactive protein are associated with impaired coronary collateral development. Eur. J. Clin. Invest. 2006;36:369–375
  58. Kerner A, Gruberg L, Goldberg A, Roguin A, Lavie P, Lavie L, et al. Relation of C-reactive protein to coronary collaterals in patients with stable angina pectoris and coronary artery disease. Am. J. Cardiol. 2007;99:509–512
  59. Verhoeff BJ, Siebes M, Meuwissen M, Atasever B, Voskuil M, de Winter RJ, et al. Influence of percutaneous coronary intervention on coronary microvascular resistance index. Circulation. 2005;111:76–82

☆ Presented previously in part in abstract form (FASEB J 21:900.12, 2007).

PII: S0022-2828(09)00185-0

doi: 10.1016/j.yjmcc.2009.04.015

Journal of Molecular and Cellular Cardiology
Volume 47, Issue 2 , Pages 196-202 , August 2009

Article Tools

* Image Usage & Resolution